Name | 4-[2-[(6R,6aR,11bR)-2-carbamimidoyl-6,6a,7,11b-tetrahydro-5H-indeno[2,1-c]quinolin-6-yl]-5-hydroxy-4-methoxyphenyl]benzoic acid |
---|---|
Synonyms |
unii-xd269g3o31
1ge |
Description | BMS-593214 is an active site-directed factor (F) VIIa inhibitor. BMS-593214 shows antithrombotic and antihaemostatic properties. BMS-593214 is a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Viia-activated substrate FX. BMS-593214 prevents electroinduced carotid artery thrombosis (AT) and wire induced vena cava thrombosis (VT)[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C31H27N3O4 |
---|---|
Molecular Weight | 505.56400 |
Exact Mass | 505.20000 |
PSA | 128.66000 |
LogP | 6.45910 |